Portolan Capital Management, LLC United Therapeutics Corp Transaction History

Portolan Capital Management, LLC

  • $1.26 Billion
  • Q3 2024

A detailed history of Portolan Capital Management, LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Portolan Capital Management, LLC holds 30,506 shares of UTHR stock, worth $11 Million. This represents 0.87% of its overall portfolio holdings.

Number of Shares
30,506
Previous 54,845 44.38%
Holding current value
$11 Million
Previous $17.5 Million 37.43%
% of portfolio
0.87%
Previous 1.55%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$311.04 - $363.55 $7.57 Million - $8.85 Million
-24,339 Reduced 44.38%
30,506 $10.9 Million
Q2 2024

Aug 14, 2024
SELL
$228.26 - $319.04 $12.8 Million - $17.9 Million
-56,077 Reduced 50.56%
54,845 $17.5 Million
Q1 2024

May 15, 2024
BUY
$210.76 - $249.51 $4.03 Million - $4.77 Million
19,114 Added 20.82%
110,922 $25.5 Million
Q4 2023

Feb 14, 2024
BUY
$214.88 - $256.94 $2.31 Million - $2.76 Million
10,760 Added 13.28%
91,808 $20.2 Million
Q3 2023

Nov 14, 2023
BUY
$211.82 - $248.24 $10.1 Million - $11.8 Million
47,582 Added 142.18%
81,048 $18.3 Million
Q2 2023

Aug 14, 2023
SELL
$205.19 - $232.99 $9.09 Million - $10.3 Million
-44,282 Reduced 56.96%
33,466 $7.39 Million
Q1 2023

May 15, 2023
SELL
$212.99 - $276.17 $227,686 - $295,225
-1,069 Reduced 1.36%
77,748 $17.4 Million
Q4 2022

Feb 13, 2023
SELL
$205.95 - $280.43 $509,314 - $693,503
-2,473 Reduced 3.04%
78,817 $21.9 Million
Q3 2022

Nov 14, 2022
SELL
$203.3 - $244.17 $722,528 - $867,780
-3,554 Reduced 4.19%
81,290 $17 Million
Q2 2022

Aug 15, 2022
BUY
$174.81 - $241.14 $14.8 Million - $20.5 Million
84,844 New
84,844 $20 Million
Q3 2020

Nov 16, 2020
SELL
$99.9 - $121.13 $7.5 Million - $9.09 Million
-75,039 Closed
0 $0
Q2 2020

Aug 14, 2020
SELL
$92.74 - $125.82 $3.69 Million - $5 Million
-39,738 Reduced 34.62%
75,039 $9.08 Million
Q1 2020

May 14, 2020
BUY
$79.39 - $115.35 $9.11 Million - $13.2 Million
114,777 New
114,777 $10.9 Million
Q1 2018

May 14, 2018
SELL
$107.21 - $151.94 $3.67 Million - $5.2 Million
-34,227 Closed
0 $0
Q4 2017

Feb 14, 2018
SELL
$118.58 - $151.28 $1.42 Million - $1.81 Million
-11,962 Reduced 25.9%
34,227 $5.06 Million
Q3 2017

Nov 14, 2017
BUY
$114.6 - $136.81 $5.29 Million - $6.32 Million
46,189
46,189 $5.41 Million

Others Institutions Holding UTHR

# of Institutions
671
Shares Held
42.3M
Call Options Held
194K
Put Options Held
295K
View Full List

About UNITED THERAPEUTICS Corp

UTHR Quotes by TradingView
  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.4B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Portolan Capital Management, LLC Portfolio

Follow Portolan Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Portolan Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Portolan Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email